Teladoc Health (TDOC) Competitors $10.62 +0.22 (+2.11%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TDOC vs. HIMS, GH, OPCH, SHC, BTSG, VCYT, SGRY, LFST, CON, and PACSShould you be buying Teladoc Health stock or one of its competitors? The main competitors of Teladoc Health include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), Veracyte (VCYT), Surgery Partners (SGRY), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), and PACS Group (PACS). These companies are all part of the "healthcare" industry. Teladoc Health vs. Hims & Hers Health Guardant Health Option Care Health Sotera Health BrightSpring Health Services Veracyte Surgery Partners LifeStance Health Group Concentra Group Holdings Parent PACS Group Hims & Hers Health (NYSE:HIMS) and Teladoc Health (NYSE:TDOC) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, community ranking, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations. Does the MarketBeat Community favor HIMS or TDOC? Teladoc Health received 640 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 62.92% of users gave Teladoc Health an outperform vote while only 37.37% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformHims & Hers HealthOutperform Votes3737.37% Underperform Votes6262.63% Teladoc HealthOutperform Votes67762.92% Underperform Votes39937.08% Is HIMS or TDOC more profitable? Hims & Hers Health has a net margin of 8.19% compared to Teladoc Health's net margin of -37.91%. Hims & Hers Health's return on equity of 10.97% beat Teladoc Health's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health8.19% 10.97% 8.29% Teladoc Health -37.91%-10.06%-4.86% Which has stronger earnings and valuation, HIMS or TDOC? Hims & Hers Health has higher earnings, but lower revenue than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$872M6.35-$23.55M$0.4457.57Teladoc Health$2.59B0.71-$220.37M-$5.77-1.84 Do insiders & institutionals believe in HIMS or TDOC? 63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by company insiders. Comparatively, 1.0% of Teladoc Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer HIMS or TDOC? In the previous week, Hims & Hers Health had 14 more articles in the media than Teladoc Health. MarketBeat recorded 28 mentions for Hims & Hers Health and 14 mentions for Teladoc Health. Teladoc Health's average media sentiment score of 0.58 beat Hims & Hers Health's score of 0.47 indicating that Teladoc Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 8 Very Positive mention(s) 6 Positive mention(s) 8 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Teladoc Health 2 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate HIMS or TDOC? Hims & Hers Health currently has a consensus target price of $20.71, indicating a potential downside of 18.22%. Teladoc Health has a consensus target price of $12.08, indicating a potential upside of 13.68%. Given Teladoc Health's higher probable upside, analysts plainly believe Teladoc Health is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 1 Sell rating(s) 8 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.38Teladoc Health 0 Sell rating(s) 14 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has more volatility & risk, HIMS or TDOC? Hims & Hers Health has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. SummaryHims & Hers Health beats Teladoc Health on 11 of the 17 factors compared between the two stocks. Ad Chaikin Analytics50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies. You can watch for it for free, right here. Get Teladoc Health News Delivered to You Automatically Sign up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TDOC vs. The Competition Export to ExcelMetricTeladoc HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE ExchangeMarket Cap$1.83B$1.03B$5.37B$20.16BDividend YieldN/AN/A5.09%3.50%P/E Ratio-1.8411.51105.6044.50Price / Sales0.711.501,246.3217.75Price / Cash11.0043.0440.1221.28Price / Book1.213.337.064.71Net Income-$220.37M-$52.07M$119.33M$986.85M7 Day Performance15.55%2.51%2.14%3.73%1 Month Performance18.06%-4.13%-3.14%3.70%1 Year Performance-37.68%-4.28%33.63%27.73% Teladoc Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TDOCTeladoc Health2.5503 of 5 stars$10.63+2.1%$12.08+13.7%-37.7%$1.83B$2.59B-1.845,600Options VolumeGap UpHIMSHims & Hers Health3.6169 of 5 stars$23.94+9.8%$20.71-13.5%+213.1%$5.23B$872M54.401,046Analyst ForecastInsider TradeHigh Trading VolumeGHGuardant Health3.9877 of 5 stars$31.09+1.3%$40.60+30.6%+40.6%$3.84B$563.95M-7.311,779OPCHOption Care Health4.9817 of 5 stars$22.46+2.7%$30.83+37.3%-23.3%$3.82B$4.30B18.397,802Positive NewsSHCSotera Health4.2362 of 5 stars$12.41-6.1%$16.50+33.0%-6.6%$3.52B$1.05B51.483,000Analyst ForecastHigh Trading VolumeBTSGBrightSpring Health Services2.8925 of 5 stars$18.75-0.2%$16.79-10.4%N/A$3.26B$8.83B-72.0835,000Positive NewsVCYTVeracyte4.1662 of 5 stars$38.94-0.7%$41.25+5.9%+51.6%$3.02B$361.05M-261.33790SGRYSurgery Partners3.1211 of 5 stars$23.36+3.8%$38.71+65.7%-29.9%$2.97B$2.74B-46.9013,500Analyst ForecastLFSTLifeStance Health Group1.7824 of 5 stars$7.31+1.2%$8.50+16.3%+15.6%$2.80B$1.06B-28.129,325CONConcentra Group Holdings ParentN/A$21.48+1.0%$28.50+32.7%N/A$2.74B$1.88B0.0011,000PACSPACS Group4.0956 of 5 stars$16.77-2.8%$39.88+137.8%N/A$2.56B$3.11B0.0032,433 Related Companies and Tools Related Companies HIMS Alternatives GH Alternatives OPCH Alternatives SHC Alternatives BTSG Alternatives VCYT Alternatives SGRY Alternatives LFST Alternatives CON Alternatives PACS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:TDOC) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teladoc Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Teladoc Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
